AVM Biotechnology
Seattle, US
Biotech
Founders & leadership
TD
Theresa DeisherCEO, Manager
Reported raises · per SEC filings
Form D private placements$4.4MraisedMay 2021 · 22 investors · Biotechnology
Rule 506(b)$1.4MraisedMay 2019 · 13 investors · Biotechnology
Rule 506(b)$5.5MraisedDec 2017 · 25 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.